RNS Number : 0483V
Cellular Goods PLC
29 November 2023

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

29 November 2023

Cellular Goods plc

("Cellular Goods" or "The Company")

Cellular Goods' products available for purchase in the Netherlands, Denmark, and Belgium.

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, is pleased to announce that products in its 'Look Better' skincare range are now available to purchase in the Netherlands, Denmark, and Belgium.

Cellular Goods' ecommerce website, selling their premium range of anti-inflammatory CBG products, has expanded its availability to three more EU markets with shipping now available to the Netherlands, Denmark, and Belgium. The Company's rejuvenating skincare range, which includes their best-selling Rejuvenating Face Serum, Rejuvenating Night Cream and Nourishing Face Oil, is formulated to protect skin from irritation, reduce redness, and prevent inflammation known to accelerate the signs of ageing. Its unique formula does so as effectively as Vitamin C and Retinol, but without the associated dryness and irritation, making it suitable for all skin types.

Other products available for shipping to the Netherlands, Denmark and Belgium include the Company's SPF25 Rejuvenating Day Cream, Rejuvenating Day Mousse and Calming Cannabinoid After Shaving Moisturiser, as well as 'mini' sizes and gift sets.

All products are available for shipping to consumers in the Netherlands, Denmark, and Belgium via the Company's ecommerce website, www.cellular-goods.com.

Darcy Taylor, Interim CEO, commented: "We are pleased to announce another significant milestone in our strategy to increase global access to our products, as we extend our skincare and wellness offerings into three dynamic CBG-friendly markets. This expansion of our e-commerce presence to Dutch, Danish and Belgian customers, supports our focus on broadening distribution channels to drive sustained revenue growth and enhance shareholder value over the long term. This step is geared towards increasing global accessibility to our breakthrough products and sharing their transformative benefits within new markets."

For further information please contact:

Cellular Goods


Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)


Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

+44 7572 873 300

+44 7572 873 300

+44 7858 888 007

Novum Securities

Corporate Broker

Colin Rowbury

Jon Belliss

+44 207 399 9427

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCMZMZMNLRGFZG